HomeMidazolamMidazolam + Atomoxetine

Does Midazolam Interact with Atomoxetine?

Midazolam and Atomoxetine have a minor drug interaction according to U.S. FDA drug labeling data. CYP3A4 substrate; atomoxetine did not cause clinically important interaction with CYP3A-metabolized drugs. The mechanism involves no clinically important cyp3a inhibition or induction. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Minor
Midazolam Class
Benzodiazepine
Management
Generally manageable
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Midazolam and Atomoxetine occurs because no clinically important cyp3a inhibition or induction. Clinically, this means cyp3a4 substrate; atomoxetine did not cause clinically important interaction with cyp3a-metabolized drugs. This is classified as a minor interaction with generally low clinical significance, though your healthcare provider should still be informed that you are taking both medications.

What To Tell Your Doctor or Pharmacist

If you are taking Midazolam and your doctor is considering prescribing Atomoxetine (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Midazolam+💊 Atomoxetine(Atomoxetine)

Severity & Interaction Details

minor
Generally safe — minor interaction
Low clinical significance. Routine awareness is usually sufficient.
Severity scale
MinorContra
On record
Yes
Drug A class
Benzodiazepine
Drug B class
Source
NLP:atomoxetine

What this means in plain English

CYP3A4 substrate; atomoxetine did not cause clinically important interaction with CYP3A-metabolized drugs.

What the FDA label says

"No clinically important CYP3A inhibition or induction"

📖 Source: NLP:atomoxetine

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Midazolam and Atomoxetine against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.